LEADER 01437nam  2200409   450 
001 9910713746603321
005 20200803102732.0
035   $a(CKB)5470000002504218
035   $a(OCoLC)1181919508
035   $a(EXLCZ)995470000002504218
100   $a20200803d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCOVID-19: data quality and considerations for modeling and analysis $ereport to congressional committees
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2020.
215   $a1 online resource (iii, 41 pages) $ccolor illustrations
300   $a"July 2020."
300   $a"GAO-20-635SP."
320   $aIncludes bibliographical references.
517   $aCOVID-19
606   $aCOVID-19 (Disease)$zUnited States$xEpidemiology
606   $aPublic health surveillance$zUnited States
606   $aHealth surveys$zUnited States$xStatistical methods
606   $aMedical policy$zUnited States
615  0$aCOVID-19 (Disease)$xEpidemiology.
615  0$aPublic health surveillance
615  0$aHealth surveys$xStatistical methods.
615  0$aMedical policy
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910713746603321
996   $aCOVID-19: data quality and considerations for modeling and analysis$93450732
997   $aUNINA